BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2501338)

  • 1. Assessment of ovaries by magnetic resonance imaging in patients presenting with polycystic ovarian syndrome.
    Faure N; Prat X; Bastide A; Lemay A
    Hum Reprod; 1989 May; 4(4):468-72. PubMed ID: 2501338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovarian syndrome.
    Takahashi K; Eda Y; Abu-Musa A; Okada S; Yoshino K; Kitao M
    Hum Reprod; 1994 Jul; 9(7):1231-6. PubMed ID: 7962423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of magnetic resonance imaging and ultrasonography for diagnosis of polycystic ovary syndrome in adolescent girls.
    Kenigsberg LE; Agarwal C; Sin S; Shifteh K; Isasi CR; Crespi R; Ivanova J; Coupey SM; Heptulla RA; Arens R
    Fertil Steril; 2015 Nov; 104(5):1302-9.e1-4. PubMed ID: 26354095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S; van der Spuy ZM
    Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families.
    Govind A; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1999 Jan; 84(1):38-43. PubMed ID: 9920059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CORRELATION OF ANTI-MULLERIAN HORMONE WITH HORMONAL AND OVARIAN MORPHOLOGICAL CHARACTERISTICS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT INSULIN RESISTANCE].
    Asanidze E; Khristesashvili J; Pkhaladze L; Barbakadze L
    Georgian Med News; 2018 Feb; (Issue):34-40. PubMed ID: 29578420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The excess in 2-5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome.
    Dewailly D; Catteau-Jonard S; Reyss AC; Maunoury-Lefebvre C; Poncelet E; Pigny P
    Hum Reprod; 2007 Jun; 22(6):1562-6. PubMed ID: 17449514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
    Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of counting follicles in diagnosis of polycystic ovary syndrome by the three-dimensional ultrasound imaging with sonography based automated volume calculation method].
    He LR; Zhou LX; Pan RK; Zhang X
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):350-4. PubMed ID: 21733371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ultrasound criterion for the diagnosis of polycystic ovary syndrome: ovarian stroma/total area ratio].
    Qiu Y; Liu J; Zhou YF; Gui WW; Liu SW; Wang FL; Zhang HY; Ma Z
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):595-7. PubMed ID: 15498185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
    Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian morphology in polycystic ovary syndrome: estimates from 2D and 3D ultrasound and magnetic resonance imaging and their correlation to anti-Müllerian hormone.
    Nylander M; Frøssing S; Bjerre AH; Chabanova E; Clausen HV; Faber J; Skouby SO
    Acta Radiol; 2017 Aug; 58(8):997-1004. PubMed ID: 28273731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.
    Dewailly D; Lujan ME; Carmina E; Cedars MI; Laven J; Norman RJ; Escobar-Morreale HF
    Hum Reprod Update; 2014; 20(3):334-52. PubMed ID: 24345633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian torsion associated with cessation of hormonal treatment for polycystic ovarian syndrome: a case report.
    Murakami M; Takiguchi E; Hayashi S; Nakagawa Y; Iwasa T
    Clin Exp Obstet Gynecol; 2013; 40(4):609-11. PubMed ID: 24597271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries.
    Franks S; Webber LJ; Goh M; Valentine A; White DM; Conway GS; Wiltshire S; McCarthy MI
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3396-402. PubMed ID: 18559912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonographic evaluation of polycystic ovaries.
    Zhu RY; Wong YC; Yong EL
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():25-37. PubMed ID: 27118252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transvaginal ultrasonographic morphology in polycystic ovarian syndrome.
    Takahashi K; Okada M; Ozaki T; Uchida A; Yamasaki H; Kitao M
    Gynecol Obstet Invest; 1995; 39(3):201-6. PubMed ID: 7789918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrinological environment with regard to the number of microcysts in patients with polycystic ovary syndrome.
    Yoshino K; Takahashi K; Eda Y; Okada S; Kitao M
    Hum Reprod; 1992 Oct; 7(9):1201-4. PubMed ID: 1478997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function.
    Carmina E; Fruzzetti F; Lobo RA
    Gynecol Endocrinol; 2018 Apr; 34(4):301-304. PubMed ID: 29073797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.